Los Angeles, United States
SPARK Neuro, founded in 2017, is a pioneering company in the Health Care and Life Sciences industries. The company underscores the urgent need to address that 40% of dementia cases remain undiagnosed, as reflected in their slogan, "40% of dementia is not diagnosed. We partner with healthcare providers and payers to change that."
SPARK Neuro aims to make brain health assessments a standard component of care. They offer a comprehensive service powered by an AI-enabled and FDA-cleared EEG brain scan, optimizing non-invasive and scalable brain health evaluations. Their collaborations with renowned institutions like the Mayo Clinic and Johns Hopkins Medicine, alongside funding from the Department of Defense and the National Institutes of Health, spotlight the company’s credibility and innovation.
In terms of financial momentum, SPARK Neuro secured a $10.00M Series A investment on 08 February 2023, with backing from investors such as AngelList, Thiel Capital, and Trajectory Ventures. The company is headquartered in the United States.
